Compile Data Set for Download or QSAR
Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 12910
TargetTyrosine-protein kinase BTK(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739796(US20250152719, Compound 50)
Affinity DataIC50: 0.420nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739796(US20250152719, Compound 50)
Affinity DataIC50: 0.810nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739794(US20250152719, Compound 27)
Affinity DataIC50: 0.960nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739797(US20250152719, Compound 59)
Affinity DataIC50: 5.40nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739793(US20250152719, Compound 10)
Affinity DataIC50: 7.10nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739794(US20250152719, Compound 27)
Affinity DataIC50: 9nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739797(US20250152719, Compound 59)
Affinity DataIC50: 9.10nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739795(US20250152719, Compound 33)
Affinity DataIC50: 11nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739793(US20250152719, Compound 10)
Affinity DataIC50: 19.6nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetTyrosine-protein kinase BTK [C481S](Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739795(US20250152719, Compound 33)
Affinity DataIC50: 22nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739796(US20250152719, Compound 50)
Affinity DataIC50: 69nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739794(US20250152719, Compound 27)
Affinity DataIC50: 109nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739797(US20250152719, Compound 59)
Affinity DataIC50: 279nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739795(US20250152719, Compound 33)
Affinity DataIC50: 785nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Chia Tai Tianqing Pharmaceutical Group

US Patent
LigandPNGBDBM739793(US20250152719, Compound 10)
Affinity DataIC50: 3.32E+3nMAssay Description:The Assay Buffer was prepared, and the composition of the Assay Buffer was 50 mM Hepes (Gibco, 15630), 10 mM MgCl2, 2 mM DTT, 1 mM EGTA, and 0.010% T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/15/2025
Entry Details
US Patent